- Decrease font
- Increase font
- Send to a friend
Click here to bookmark this page
Customize your Bookmarks:
- Type the name of the page the way you would like it to appear in "My Bookmarks";
- Click in the "Add as My Bookmarks" button.
To choose your favorite sessions, please click here.
CCENTRO DE IMAGEM DIAGNÓSTICOS S.A. ("Company") (B3: AALR3), in compliance with paragraph 4 of article 157 of Law 6404/76 and Instruction 44/2021 of the Brazilian Securities and Exchange Commission ("CVM"), hereby informs its shareholders and the market in general that received, on this date, from the representative of the shareholders of the Companys controlling block, signatories of the shareholders agreement signed on August 20, 2021, as amended (respectively, "Shareholders Agreement" and "Controlling Shareholders"), notice for disclosure to the market stating that, in the form and in accordance with the applicable provisions of the Shareholders Agreement, the Controlling Shareholders resolved to accept the proposal for the acquisition of up to the totality of the shares issued by the Company held by the Controlling Shareholders for the price per share of BRL 20.50. The proposal was sent on the 18th of November 2021 by MAM ASSET MANAGEMENT GESTORA DE RECURSOS LTDA. ("MAM"), CNPJ/ME under No. 21.180.163/0001-73, as manager of the investment fund Fonte de Saúde Fundo de Investimento em Participações Multiestratégia, holder of a shareholding representing 27.87% in the capital of the Company. The content of that notice is attached to this material fact.
The Company reiterates its commitment to keep the market informed about material facts and acts, in compliance with applicable regulations.
São Paulo, November 26th, 2021.
To access the full document, click here.